JP2022518771A5 - - Google Patents
Info
- Publication number
- JP2022518771A5 JP2022518771A5 JP2021542444A JP2021542444A JP2022518771A5 JP 2022518771 A5 JP2022518771 A5 JP 2022518771A5 JP 2021542444 A JP2021542444 A JP 2021542444A JP 2021542444 A JP2021542444 A JP 2021542444A JP 2022518771 A5 JP2022518771 A5 JP 2022518771A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- population
- subject
- neutrophils
- pathogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795498P | 2019-01-22 | 2019-01-22 | |
| US62/795,498 | 2019-01-22 | ||
| PCT/US2020/014642 WO2020154424A1 (en) | 2019-01-22 | 2020-01-22 | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518771A JP2022518771A (ja) | 2022-03-16 |
| JP2022518771A5 true JP2022518771A5 (https=) | 2023-01-26 |
| JP7670614B2 JP7670614B2 (ja) | 2025-04-30 |
Family
ID=71735513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542444A Active JP7670614B2 (ja) | 2019-01-22 | 2020-01-22 | 抗原提示好中球由来樹状細胞およびその使用方法 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US12589140B2 (https=) |
| JP (1) | JP7670614B2 (https=) |
| WO (1) | WO2020154424A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020154424A1 (en) | 2019-01-22 | 2020-07-30 | The Brigham And Women's Hospital, Inc. | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof |
| US20250270326A1 (en) * | 2020-12-23 | 2025-08-28 | The Regents Of The University Of California | Methods of treating respiratory disorders |
| JP7607539B2 (ja) * | 2021-09-24 | 2024-12-27 | 東京エレクトロン株式会社 | プラズマ処理装置及び処理方法 |
| EP4601682A1 (en) * | 2022-10-13 | 2025-08-20 | The Brigham & Women's Hospital, Inc. | Methods and compositions for improving response to immunotherapy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4662393A (en) * | 1992-07-08 | 1994-01-31 | Schering Corporation | Use of gm-csf as a vaccine adjuvant |
| JP2001061469A (ja) | 1999-08-24 | 2001-03-13 | Japan Science & Technology Corp | 免疫応答誘導樹状細胞の調製方法 |
| US7906118B2 (en) * | 2005-04-06 | 2011-03-15 | Ibc Pharmaceuticals, Inc. | Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| JP2004189724A (ja) | 2002-11-29 | 2004-07-08 | Toray Ind Inc | 生理活性物質を含む材料およびその製造方法 |
| WO2006073921A2 (en) | 2004-12-30 | 2006-07-13 | The Rockefeller University | Compositions and methods for enhanced dendritic cell maturation and function |
| WO2009111396A1 (en) | 2008-03-03 | 2009-09-11 | University Of Toledo | Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof |
| ES3000111T3 (en) | 2009-02-13 | 2025-02-27 | Immunomedics Inc | Intermediates for preparing conjugates with an intracellularly-cleavable linkage |
| KR20130108295A (ko) | 2010-08-13 | 2013-10-02 | 베일러 리서치 인스티튜트 | 항원-제시 세포에 항체에 대한 보조제를 직접 표적화함을 기초로 하는 신규 백신 보조제 |
| ES2692268T5 (en) * | 2011-03-29 | 2025-02-26 | Roche Glycart Ag | Antibody fc variants |
| SI2788474T1 (sl) | 2012-12-18 | 2016-01-29 | Immunicum Ab | Ko-diferenciacija monocitov iz alogenskih darovalcev |
| WO2017040374A1 (en) | 2015-08-31 | 2017-03-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods of enhancing anti-tumor response using hybrid neutrophils |
| JP6753143B2 (ja) | 2016-05-31 | 2020-09-09 | 東ソー株式会社 | ＦｃγＲＩＩａをコードするポリヌクレオチド及びＦｃγＲＩＩａの製造方法 |
| WO2020154424A1 (en) | 2019-01-22 | 2020-07-30 | The Brigham And Women's Hospital, Inc. | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof |
-
2020
- 2020-01-22 WO PCT/US2020/014642 patent/WO2020154424A1/en not_active Ceased
- 2020-01-22 JP JP2021542444A patent/JP7670614B2/ja active Active
- 2020-01-22 US US17/424,431 patent/US12589140B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518771A5 (https=) | ||
| JP5100760B2 (ja) | Ｈｂｖワクチンおよびその製造方法 | |
| Kreutz et al. | Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity | |
| JP3583420B2 (ja) | 二特異的試薬を用いた標的免疫化 | |
| US8999398B2 (en) | Polyclonal bispecific antibody compositions and method of use | |
| Jobsri et al. | Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody | |
| JP6882184B2 (ja) | 多価ｂ型肝炎ウイルス抗原結合分子およびその使用 | |
| JP6811723B2 (ja) | 多価ヒト免疫不全ウイルス抗原結合分子およびその使用方法 | |
| RU2016130447A (ru) | Гетеродимерный белок il-15 и его применения | |
| JP6440259B2 (ja) | Ｈｂｖ感染及び関連疾患を処置するためのポリペプチド及び抗体 | |
| Kennedy et al. | CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen | |
| Chuai et al. | Poly (I: C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting | |
| US20020164312A1 (en) | Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells | |
| Ibañez et al. | M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A | |
| JP2010523724A (ja) | α−ガラクトシルセラミド類似体およびそれらの免疫療法剤としての使用 | |
| CN1662253A (zh) | 用作佐剂的包装的病毒样颗粒:制备方法与用途 | |
| JP2017538672A (ja) | Ｃｍｖ由来改変ウイルス様粒子 | |
| KR20090114466A (ko) | 덱틴-1을 통한 사람 항원제시세포 활성화의 치료학적 적용 | |
| Song et al. | Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice | |
| JP2021533134A (ja) | チェックポイント阻害抗体と相乗効果を示し、疾患を排除するｔｌｒ１／２アゴニストジプロボッシムのアジュバント効果 | |
| WO2020038355A1 (zh) | Tim-3抗体在制备治疗肿瘤的药物中的用途 | |
| Betting et al. | Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells | |
| JP2022525400A (ja) | フルオレセインエーテルリン脂質またはフルオレセインエーテルリン脂質前駆体と併用した抗フルオレセインｃａｒ ｔ細胞に対する拮抗薬としてのフルオレセインナトリウム | |
| WO2005117983A3 (en) | Carrier conjugates of tnf-peptides | |
| US7118924B2 (en) | Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents |